Medicare Enrolled

Dr. Jay Levinson, MD

Gastroenterology · Farmington Hills, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
30055 NORTHWESTERN HWY, Farmington Hills, MI 48334
2489855000
In practice since 2005 (20 years)
NPI: 1275516692 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Levinson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Levinson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Levinson

Dr. Jay Levinson is a gastroenterology specialist in Farmington Hills, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Levinson performed 13,476 Medicare services across 891 unique beneficiaries.

Between the years covered by Open Payments, Dr. Levinson received a total of $12,180 from 49 pharmaceutical and/or device companies across 727 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Levinson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 1% volume in MI $12,180 industry payments

Medicare Practice Summary

Medicare Utilization ↗
13,476
Medicare services
Top 1% in MI for gastroenterology
891
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~674 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Vedolizumab infusion (Entyvio)
This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams.
10,500 $17 $29
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
1,931 $26 $150
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
376 $99 $180
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
96 $131 $750
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
92 $193 $700
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
91 $129 $300
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
88 $221 $800
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
77 $82 $550
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
77 $105 $360
Upper endoscopy (EGD)
A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope.
46 $74 $400
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
42 $23 $100
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
34 $194 $700
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
26 $149 $700
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
92.8% high complexity
3.1% medium
4.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$12,180
Total received (2018-2024)
Avg $1,740/year across 7 years
Top 13% in MI for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
727
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,168 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,894
2023
$2,355
2022
$2,077
2021
$1,448
2020
$306
2019
$1,755
2018
$1,343

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$659
Takeda Pharmaceuticals U.S.A., Inc.
$532
Janssen Biotech, Inc.
$341
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$197
PFIZER INC.
$163
Celgene Corporation
$161
Ardelyx, Inc.
$87
Lilly USA, LLC
$86
Intercept Pharmaceuticals, Inc.
$85
AIMMUNE THERAPEUTICS, INC.
$83
Regeneron Healthcare Solutions, Inc.
$76
Sandoz Inc.
$64
Madrigal Pharmaceuticals
$58
Gilead Sciences, Inc.
$53
IRONWOOD PHARMACEUTICALS, INC
$51
GENZYME CORPORATION
$47
QOL Medical, LLC
$45
Organon Llc
$42
Ferring Pharmaceuticals Inc.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Phathom Pharmaceuticals, Inc.
$15
Top 3 companies account for 52.9% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,742
Takeda Pharmaceuticals U.S.A., Inc.
$1,631
Janssen Biotech, Inc.
$1,161
Celgene Corporation
$1,106
PFIZER INC.
$786
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$700
Gilead Sciences, Inc.
$533
AbbVie, Inc.
$472
GENZYME CORPORATION
$410
Ironwood Pharmaceuticals, Inc
$401
Regeneron Healthcare Solutions, Inc.
$285
Ferring Pharmaceuticals Inc.
$266
AbbVie Inc.
$200
Intercept Pharmaceuticals, Inc.
$158
UCB, Inc.
$157
Nestle HealthCare Nutrition Inc.
$151
Merck Sharp & Dohme Corporation
$148
Braintree Laboratories, Inc.
$120
Ardelyx, Inc.
$118
Allergan Inc.
$117
Amgen Inc.
$117
Sandoz Inc.
$113
E.R. Squibb & Sons, L.L.C.
$98
QOL Medical, LLC
$93
Lilly USA, LLC
$86
AIMMUNE THERAPEUTICS, INC.
$83
INTERCEPT PHARMACEUTICALS, INC.
$79
NESTLE HEALTHCARE NUTRITION INC.
$78
Merck Sharp & Dohme LLC
$76
Daiichi Sankyo Inc.
$76
IRONWOOD PHARMACEUTICALS, INC
$66
Boehringer Ingelheim Pharmaceuticals, Inc.
$65
Synergy Pharmaceuticals Inc
$65
Madrigal Pharmaceuticals
$58
Fresenius Kabi USA, LLC
$49
Organon Llc
$42
Romark Laboratories, LC
$37
Welch Allyn
$34
Shionogi Inc
$34
Alnylam Pharmaceuticals Inc.
$33
Mylan Institutional Inc.
$21
Prometheus Laboratories Inc.
$16
Organon LLC
$16
Shire North American Group Inc
$15
Phathom Pharmaceuticals, Inc.
$15
AstraZeneca Pharmaceuticals LP
$15
Cook Medical LLC
$13
RedHill Biopharma Inc.
$12
AMAG Pharmaceuticals, Inc.
$12
Top 3 companies account for 37.2% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · ANDEXXA · APRISO · AVSOLA · Aemcolo · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · CIMZIA · CLENPIQ · CREON · CYCLOSET · CYLTEZO · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · EOHILIA · Entyvio · Epclusa · FERAHEME · GATTEX · GIVLAARI · HADLIMA · HUMIRA · HYRIMOZ · Hulio · Humira · IBSRELA · INFLECTRA · INJECTAFER · Instinct · LINZESS · Linzess · MAVYRET · MOTEGRITY · Mavyret · OCALIVA · OMVOH · Propaq Monitor · REBYOTA · RELISTOR · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · Symproic · TREMFYA · TRULANCE · Trulance · VIBERZI · VOQUEZNA · VOWST · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a gastroenterology specialist in Farmington Hills?
Compare gastroenterologists in the Farmington Hills area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
184
Per 100K population
14.5
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL - FARMINGTON HILLS
2.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Levinson is a mixed practice specialist, with above-average Medicare volume (top 1% in MI), with low-engagement industry engagement in the top 13% of MI peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Levinson experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Levinson performed 10,500 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Levinson receive payments from pharmaceutical companies?
Yes. Dr. Levinson received a total of $12,180 from 49 companies across 727 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Levinson's costs compare to other gastroenterologists in Farmington Hills?
Dr. Levinson's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Levinson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →